COVID-19 Treatments

Using nirmatrelvir and ritonavir (Paxlovid) in practice

14 February 2022Advice on use in swallowing difficulties, pregnancy and breastfeeding, and signposting to advice to give to patients.

Using molnupiravir in practice

9 February 2022Advice on swallowing difficulties, use in pregnancy and breastfeeding, and signposting to advice to give to patients.

Medicines interactions with nirmatrelvir and ritonavir (Paxlovid®)

28 January 2022Guidance on interacting drugs to be used alongside the NHSE/I commissioning policy for Paxlovid®, containing PF-07321332 (nirmatrelvir) and ritonavir.

Registration required

Managing risk when supplying and administering COVID-19 treatments from acute Trusts

20 December 2021Three models exist for the supply and administration of COVID-19 treatments through CMDUs. We guide through the risks and mitigations associated with each.

Registration required

Managing nMABs and OAVs under CMDU arrangements across legal entities

20 December 2021Chief Pharmacists may need to oversee and manage prescription and supply of nMABs and oral antivirals in CMDUs. Use our framework and resources to help.

Using COVID-19 oral antivirals in practice

15 December 2021Deployment should address a range of factors and be implemented through different mechanisms. Collecting data and learning will support continued safe use.

Getting ready to use sotrovimab: guidance for Chief Pharmacists

14 December 2021This guidance for Chief Pharmacists supports the pharmacy institutional readiness for the management of sotrovimab in COVID-19 infection.

Handling and preparation of sotrovimab

14 December 2021An outline process and supporting materials to help Trusts deploy sotrovimab

Preparing Casirivimab 600mg Imdevimab 600mg using 2.5mL vials

5 November 2021Worksheets and instructions for preparing this given dose and volume combination of Ronapreve

Preparing Casirivimab 600mg Imdevimab 600mg using 11.1mL vials